Neutrophilia Management
Introduction to Neutrophilia
- The primary treatment for neutrophilia should target the underlying cause, as neutrophilia is typically a symptom rather than a disease itself, according to the National Comprehensive Cancer Network 1
Diagnosis and Assessment
- Neutropenia is defined as an absolute neutrophil count (ANC) <500 cells/mm³ expected to last ≥7 days, or ANC <100 cells/mm³, or significant comorbidities, as defined by the Infectious Diseases Society of America 2
- The absolute neutrophil count (ANC) should be considered when evaluating neutropenia, rather than just the percentage, as recommended by the National Comprehensive Cancer Network and the American College of Physicians 3
- Serial complete blood counts should be performed to track neutrophil trends, and response to treatment of underlying condition should be assessed, as recommended by the European Society for Medical Oncology 4
Infection Management
- For bacterial infections, identify the source through appropriate cultures and initiate empiric antibiotics based on likely pathogens and site of infection, then adjust antibiotics based on culture results and clinical response, and continue until the patient is afebrile for 48 hours and infection has resolved, as recommended by the European Society for Medical Oncology 4
Empiric antibiotic regimens for neutropenic fever include:
Antibiotic Dosage Cefepime 2g IV every 8 hours Piperacillin-tazobactam 4.5g IV every 6-8 hours Carbapenem 1g IV every 8 hours Oral therapy with ciprofloxacin (500-750mg every 12 hours) plus amoxicillin-clavulanate (875/125mg every 12 hours) is recommended for low-risk patients with neutropenia, with the following dosages:
Antibiotic Dosage Augmentin 875/125 mg every 12 hours Ciprofloxacin 500-750 mg every 12 hours - Aminoglycoside monotherapy should never be used due to rapid emergence of resistance, as recommended by the Infectious Diseases Society of America 2
- Vancomycin is not recommended as part of standard empiric therapy but should be added in specific circumstances, such as hemodynamic instability, severe sepsis, or suspected catheter-related infection, as per the Infectious Diseases Society of America 2
Underlying Condition Management
- For hematologic malignancies, treat the underlying malignancy according to appropriate oncologic protocols, as recommended by the National Comprehensive Cancer Network 1
- For solid tumors with paraneoplastic neutrophilia, address the primary malignancy and manage infections aggressively due to increased risk, as recommended by the National Comprehensive Cancer Network 1
- For conditions with pathologic neutrophil activation, such as ARDS or severe inflammatory conditions, the European Respiratory Society suggests that anti-TNF therapy may be considered in specific cases of neutrophil-mediated inflammation, and anti-IL-17 or anti-CXCR2 therapies are investigational, as stated by 6
Prevention and Prophylaxis
- Patients at high risk of infection, such as those with ANC <100 cells/mm³ expected to last ≥7 days following cytotoxic chemotherapy, should consider fluoroquinolone prophylaxis (levofloxacin preferred), as recommended by the Infectious Diseases Society of America 3, 7, 8
- Autologous stem cell transplant recipients, lymphoma, multiple myeloma, and CLL patients with expected neutropenia duration 7-10 days should consider fluoroquinolone prophylaxis, antifungal prophylaxis if mucositis is present, and PJP prophylaxis, as recommended by the National Comprehensive Cancer Network 3
- Allogeneic stem cell transplant recipients and acute leukemia patients with expected neutropenia >10 days or ANC <100 cells/mm³ should receive fluoroquinolone prophylaxis, antifungal prophylaxis, PJP prophylaxis, and antiviral prophylaxis, with more stringent environmental controls, as per the Infectious Diseases Society of America and the National Comprehensive Cancer Network guidelines 9, 3
Patient Care and Support
- Patients should receive dietary restrictions, including well-cooked foods only, no raw fruits or vegetables unless thoroughly washed and peeled, and no raw or undercooked meat, eggs, or seafood, as recommended by the Infectious Diseases Society of America 9
- Personal hygiene measures, including daily bathing with antimicrobial soap, meticulous oral care, and avoidance of rectal thermometers, suppositories, and enemas, should be implemented to prevent infection, as per the Infectious Diseases Society of America guidelines 9
- The Centers for Disease Control and Prevention (CDC) recommends strict hand washing for patients, visitors, and healthcare workers, with private room with HEPA filtration for high-risk patients, and avoidance of exposure to plants, stagnant water, and construction areas, to prevent infection 9
Discharge and Follow-up
- Discharge criteria include being afebrile for at least 48 hours, clinically stable with improving symptoms, able to tolerate oral medications, having reliable access to healthcare within 1 hour of home, and having adequate home support and understanding of warning signs, as recommended by the Infectious Diseases Society of America 2, 10
- Schedule follow-up appointment within 2-3 days after discharge and arrange for laboratory monitoring, including complete blood count with differential, renal and liver function tests, and additional labs based on specific infections if identified, as recommended by the Infectious Diseases Society of America 2